Literature DB >> 11352250

A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care.

E Yelin1, A Herrndorf, L Trupin, D Sonneborn.   

Abstract

OBJECTIVE: To provide estimates of all medical care expenditures on behalf of persons with musculoskeletal conditions in the United States in 1996, to estimate the increment in expenditures attributable to the musculoskeletal conditions among such persons, and to ascertain the impact of the presence or absence of health insurance and/or managed care on such expenditures.
METHODS: The estimates were derived from the Medical Expenditure Panel Survey (MEPS), a national probability sample of 9,488 households, which includes responses from 21,571 persons. In the MEPS, respondents are surveyed every 6 months to report on medical care utilization and health care expenditures. Of the 21,571 persons surveyed, 4,161 reported having 1 or more musculoskeletal conditions. After weighting the data, these 4,161 individuals were inferred to represent 53.935 million persons in the nation as a whole. We tabulated all medical care expenditures of these individuals, stratified by comorbidity status, and then compared their expenditures with those among persons with chronic conditions other than musculoskeletal disease or with no chronic conditions. We then used regression techniques to estimate the increment of health care expenditures attributable to the musculoskeletal conditions. Finally, we used regression to estimate the impact of health insurance status and managed care status on the health care expenditures of the persons with musculoskeletal conditions.
RESULTS: Per capita medical care expenditures in 1996 averaged $3,578 among persons with musculoskeletal conditions, for a national total of $193 billion, the equivalent of 2.5% of the Gross Domestic Product in that year. The largest components were hospital admissions (37%), physician visits (23%), and prescriptions (16%). Estimates of the per capita increment in total medical care expenditures attributable to musculoskeletal conditions ranged from a high of $723 when controlling for the other medical conditions present, to $364 when controlling for these variables and demographics. Persons with musculoskeletal conditions ages 16-64 who lacked health insurance reported total expenditures of $793, versus $3,249 among those with insurance (P < 0.0001). Among such persons with insurance, expenditures did not differ significantly between those in fee-for-service plans and those in managed care health plans.
CONCLUSION: Persons with musculoskeletal conditions and health insurance experienced high total expenditures for medical care and high expenditures attributable to the musculoskeletal conditions. Insurance coverage under a managed care plan had no effect on the magnitude of these total expenditures, but lack of insurance coverage did have a significant effect among persons with musculoskeletal conditions.

Entities:  

Mesh:

Year:  2001        PMID: 11352250     DOI: 10.1002/1529-0131(200105)44:5<1160::AID-ANR199>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

1.  Prescription Opioid Use and Satisfaction With Care Among Adults With Musculoskeletal Conditions.

Authors:  Brian D Sites; Jordon Harrison; Michael D Herrick; Melissa M Masaracchia; Michael L Beach; Matthew A Davis
Journal:  Ann Fam Med       Date:  2018-01       Impact factor: 5.166

Review 2.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Design, implementation and prospective evaluation of a new interactive musculoskeletal module for medical students in Ireland.

Authors:  M H Vioreanu; B J O'Daly; M J Shelly; B M Devitt; J M O'Byrne
Journal:  Ir J Med Sci       Date:  2012-10-06       Impact factor: 1.568

4.  Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; A Spoorenberg; H Schouten; M Rutten-van Mölken; F Guillemin; M Dougados; H Mielants; K de Vlam; H van der Tempel; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

5.  Trends in out-of-pocket medical care expenditures for Medicare-age adults with arthritis between 1998 and 2004.

Authors:  Ithai Z Lurie; Dorothy D Dunlop; Larry M Manheim
Journal:  Arthritis Rheum       Date:  2008-08

6.  Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; F Guillemin; M Rutten-van Mölken; M Dougados; H Mielants; K de Vlam; H van der Tempel; S Boesen; A Spoorenberg; H Schouten; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

7.  Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997.

Authors:  Edward Yelin; Louise Murphy; Miriam G Cisternas; Aimee J Foreman; David J Pasta; Charles G Helmick
Journal:  Arthritis Rheum       Date:  2007-05

8.  Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus.

Authors:  Pantelis Panopalis; Jinoos Yazdany; Joann Zell Gillis; Laura Julian; Laura Trupin; Aimee O Hersh; Lindsey A Criswell; Patricia Katz; Edward Yelin
Journal:  Arthritis Rheum       Date:  2008-12-15

9.  The impact of trained patient educators on musculoskeletal clinical skills attainment in pre-clerkship medical students.

Authors:  Anna E Oswald; Mary J Bell; Jeffrey Wiseman; Linda Snell
Journal:  BMC Med Educ       Date:  2011-09-23       Impact factor: 2.463

10.  Teaching musculoskeletal examination skills to UK medical students: a comparative survey of Rheumatology and Orthopaedic education practice.

Authors:  Tim Blake
Journal:  BMC Med Educ       Date:  2014-03-28       Impact factor: 2.463

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.